Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myriad Neuroscience
Mason, Ohio, United Statesmyriad.com ↗
- Ownership
- Private
- Employees
- ~192
- Development stage
- Other
01
Overview
Myriad Neuroscience offers the GeneSight® pharmacogenomic test, which analyzes genetic variations affecting patient response to psychiatric medications. The test has been validated in multiple clinical studies and helps guide medication selection for depression and related mental health conditions.
- Therapeutic areas
- Psychiatry
- Modalities
- Diagnostic test
- Industry
- Molecular Diagnostics
02
Partnerships
Mayo ClinicCincinnati Children’s Hospital Medical Center
Beyond the preview
Go deeper on Myriad Neuroscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myriad Neuroscience.